Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Current Assets (2016 - 2025)

Historic Current Assets for Healthstream (HSTM) over the last 17 years, with Q3 2025 value amounting to $147.6 million.

  • Healthstream's Current Assets rose 132.24% to $147.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $147.6 million, marking a year-over-year increase of 132.24%. This contributed to the annual value of $153.1 million for FY2024, which is 1759.62% up from last year.
  • Per Healthstream's latest filing, its Current Assets stood at $147.6 million for Q3 2025, which was up 132.24% from $144.4 million recorded in Q2 2025.
  • Over the past 5 years, Healthstream's Current Assets peaked at $169.7 million during Q1 2025, and registered a low of $95.3 million during Q2 2022.
  • Its 5-year average for Current Assets is $127.0 million, with a median of $125.1 million in 2023.
  • Its Current Assets has fluctuated over the past 5 years, first crashed by 4455.05% in 2021, then soared by 2379.03% in 2023.
  • Quarter analysis of 5 years shows Healthstream's Current Assets stood at $106.8 million in 2021, then rose by 7.05% to $114.4 million in 2022, then increased by 13.84% to $130.2 million in 2023, then increased by 17.6% to $153.1 million in 2024, then decreased by 3.62% to $147.6 million in 2025.
  • Its last three reported values are $147.6 million in Q3 2025, $144.4 million for Q2 2025, and $169.7 million during Q1 2025.